Inflammatory bowel disease emergencies.

[1]  Samir A. Shah,et al.  Ocular Manifestations of Inflammatory Bowel Disease , 2004, Inflammatory bowel diseases.

[2]  M. Regueiro,et al.  Treatment of Perianal Fistulizing Crohn's Disease with Infliximab Alone or as an Adjunct to Exam Under Anesthesia with Seton Placement , 2003, Inflammatory bowel diseases.

[3]  J. Lewis,et al.  Efficacy of anti-tumor necrosis factor therapy in patients with ulcerative colitis. , 2002 .

[4]  M. Regueiro.  The role of endoscopy in the evaluation of fistulizing Crohn's disease. , 2002, Gastrointestinal endoscopy clinics of North America.

[5]  J. García,et al.  Abscesses in Crohn's disease: outcome of medical versus surgical treatment. , 2001 .

[6]  W. Chey.  Infliximab for patients with refractory ulcerative colitis. , 2001, Inflammatory bowel diseases.

[7]  G. Lichtenstein.  Is infliximab effective for induction of remission in patients with ulcerative colitis? , 2001, Inflammatory bowel diseases.

[8]  B. Sands,et al.  Biological therapies for ulcerative colitis. , 2001, Acta gastro-enterologica Belgica.

[9]  S. Hanauer,et al.  Advanced Therapy of Inflammatory Bowel Disease , 2000 .

[10]  M. Sans,et al.  Comparison of heparin and steroids in the treatment of moderate and severe ulcerative colitis. , 2000, Gastroenterology.

[11]  B. White,et al.  Randomized comparison of unfractionated heparin with corticosteroids in severe active inflammatory bowel disease , 2000, Alimentary pharmacology & therapeutics.

[12]  F. Ficari,et al.  Strictureplasty in Crohn's disease , 2000, Diseases of the colon and rectum.

[13]  C. Garrard,et al.  Laparostomy for severe intra-abdominal infection complicating colorectal disease , 2000, Diseases of the colon and rectum.

[14]  D. Lichtenstein,et al.  Hepatobiliary manifestations of inflammatory bowel disease. , 1999, Gastroenterology clinics of North America.

[15]  C. Folwaczny,et al.  Unfractioned heparin in the therapy of patients with highly active inflammatory bowel disease , 1999, American Journal of Gastroenterology.

[16]  P. Rutgeerts,et al.  Infliximab for the treatment of fistulas in patients with Crohn's disease. , 1999, The New England journal of medicine.

[17]  K. Batts,et al.  Recurrence of primary sclerosing cholangitis following liver transplantation , 1999, Hepatology.

[18]  A. Kam,et al.  The factor V Leiden mutation increases the risk of venous thrombosis in patients with inflammatory bowel disease. , 1998, Gastroenterology.

[19]  D. Jewell,et al.  Intravenous cyclosporin as rescue therapy in severe ulcerative colitis: time for a reappraisal? , 1998, European journal of gastroenterology & hepatology.

[20]  D. Jewell,et al.  The management of severe ulcerative colitis , 1997, Alimentary pharmacology & therapeutics.

[21]  M. Starlinger,et al.  Perianal abscess in Crohn's disease , 1997, Diseases of the colon and rectum.

[22]  K. Lindor.  Ursodiol for Primary Sclerosing Cholangitis , 1997 .

[23]  J. Devière.  Therapeutic Endoscopy and Primary Sclerosing Cholangitis , 1996, Endoscopy.

[24]  M. Manns,et al.  Endoscopic management of biliary tract strictures in primary sclerosing cholangitis. , 1996, Endoscopy.

[25]  C. Prantera,et al.  An antibiotic regimen for the treatment of active Crohn's disease: a randomized, controlled clinical trial of metronidazole plus ciprofloxacin. , 1996, The American journal of gastroenterology.

[26]  M. Raizman,et al.  Treatment strategies for scleritis and uveitis associated with inflammatory bowel disease. , 1994, American journal of ophthalmology.

[27]  J. Bancewicz,et al.  Reconstructive abdominal operations after laparostomy and multiple repeat laparotomies for severe intra‐abdominal infection , 1994, The British journal of surgery.

[28]  J. Neuberger,et al.  Fibrous and obliterative cholangitis in liver allografts: Evidence of recurrent primary sclerosing cholangitis? , 1994, Hepatology.

[29]  S. Hanauer,et al.  Cyclosporine in severe ulcerative colitis refractory to steroid therapy. , 1994, The New England journal of medicine.

[30]  M. Kaplan,et al.  A double-blind controlled trial of oral-pulse methotrexate therapy in the treatment of primary sclerosing cholangitis. , 1994, Gastroenterology.

[31]  M. Panos,et al.  Toxic megacolon: the knee-elbow position relieves bowel distension. , 1993, Gut.

[32]  A. Pick,et al.  Laparostomy: a technique for the management of severe abdominal sepsis. , 1993, The Australian and New Zealand journal of surgery.

[33]  E. Dickson,et al.  Efficacy of hepatic transplantation in patients with primary sclerosing cholangitis. , 1993, Surgery, gynecology & obstetrics.

[34]  F. Seibold,et al.  Clinical significance of antibodies against neutrophils in patients with inflammatory bowel disease and primary sclerosing cholangitis. , 1992, Gut.

[35]  P. Rutgeerts,et al.  Endoscopic balloon dilation of colonic and ileo-colonic Crohn's strictures: long-term results. , 1992, Gastrointestinal endoscopy.

[36]  R. Jeffrey,et al.  Gonadal vein thrombosis in patients with acute gastrointestinal inflammation: diagnosis with CT. , 1991, Radiology.

[37]  A. Hemming,et al.  Surgical versus percutaneous drainage of intra-abdominal abscesses. , 1991, American journal of surgery.

[38]  E. Fishman,et al.  Crohn disease in the pediatric patient: CT evaluation. , 1991, Radiology.

[39]  D. Sachar,et al.  Severe gastrointestinal hemorrhage in Crohn's disease. , 1991, Annals of surgery.

[40]  J. Murray,et al.  Perirectal abscess in Crohn's disease , 1990, Diseases of the colon and rectum.

[41]  P. Tam,et al.  Intra-abdominal abscesses in Crohn's disease. , 1990, The American surgeon.

[42]  A. Ruby,et al.  Crohn's disease and retinal vascular disease. , 1990, American journal of ophthalmology.

[43]  J. Orloff,et al.  Toxic megacolon in cytomegalovirus colitis. , 1989, The American journal of gastroenterology.

[44]  Kiff Rs,et al.  Fatal cerebral venous thrombosis complicating acute ulcerative colitis. , 1989 .

[45]  A. Zinsmeister,et al.  Effect of proctocolectomy for chronic ulcerative colitis on the natural history of primary sclerosing cholangitis. , 1989, Gastroenterology.

[46]  S. Meranze,et al.  Percutaneous drainage of abscesses in patients with Crohn's disease , 1988, Gastrointestinal Radiology.

[47]  J. Cronan,et al.  Percutaneous drainage of abscesses in patients with Crohn disease. , 1988, AJR. American journal of roentgenology.

[48]  R. Caprilli,et al.  Early recognition of toxic megacolon. , 1987, Journal of clinical gastroenterology.

[49]  M. Levine.  Crohn's disease of the upper gastrointestinal tract. , 1987, Radiologic clinics of North America.

[50]  J. Newman,et al.  Ulcerative colitis complicated by Budd-Chiari syndrome. , 1986, Gut.

[51]  R. Beart,et al.  Vascular complications of inflammatory bowel disease. , 1986, Mayo Clinic proceedings.

[52]  R. Kozarek.  Hydrostatic balloon dilation of gastrointestinal stenoses: a national survey. , 1986, Gastrointestinal endoscopy.

[53]  D. Schrag,et al.  Outcome of toxic dilatation in ulcerative and Crohn's colitis. , 1985, Journal of clinical gastroenterology.

[54]  A. Schachat,et al.  Primary, secondary and coincidental ocular complications of Crohn's disease. , 1984, Ophthalmology.

[55]  A. Axon,et al.  Controlled trial of intravenous hyperalimentation and total bowel rest as an adjunct to the routine therapy of acute colitis. , 1980, Gastroenterology.

[56]  B. Pasternack,et al.  Treatment of Crohn's disease with 6-mercaptopurine. A long-term, randomized, double-blind study. , 1980, The New England journal of medicine.

[57]  J. Schneiderman,et al.  Cerebral and retinal vascular complications of inflammatory bowel disease , 1979, Annals of neurology.

[58]  D. Lebrec,et al.  Gastrointestinal bleeding due to chronic portal vein thrombosis in ulcerative colitis , 1979, Digestive Diseases and Sciences.

[59]  M. Stuart,et al.  Hemostatic alterations in inflammatory bowel disease , 1978, The American Journal of Digestive Diseases.

[60]  H. Cooper,et al.  Cytomegalovirus inclusions in patients with ulcerative colitis and toxic dilation requiring colonic resection. , 1977, Gastroenterology.

[61]  S. K. Park,et al.  Crohn's disease of the duodenum. , 1977, Gut.

[62]  L. Wise,et al.  The Surgical Management of Toxic Dilatation of the Colon: A Report of 28 Cases and Review of the Literature , 1976, Annals of surgery.

[63]  R. Adelman,et al.  Association of inflammatory bowel disease and large vascular lesions. , 1976, Gastroenterology.

[64]  I. Borda,et al.  Coagulation studies in ulcerative colitis and Crohn's disease. , 1975, Gastroenterology.

[65]  I. Leopold,et al.  Advances in ocular corticosteroid therapy. , 1973, The Medical clinics of North America.

[66]  D. Beton,et al.  Crohn's disease of the stomach and duodenum , 1970, Gut.

[67]  W. Card,et al.  An experience of ulcerative colitis. I. Toxic dilation in 55 cases. , 1969, Gastroenterology.

[68]  L. Schoenfield,et al.  Regional enteritis with involvement of the duodenum. , 1966, Gastroenterology.

[69]  A. H. Baggenstoss,et al.  Venous Thrombosis Occurring in Nonspecific Ulcerative Colitis: A Necropsy Study , 1966 .

[70]  D. Present,et al.  Favorable effect of 6-Mercaptopurine on fistulae of Crohn's disease , 2005, Digestive Diseases and Sciences.

[71]  Noel Sanchez.  Lower Gastrointestinal Bleeding , 2003 .

[72]  J. Rosenbaum,et al.  Uveitis associated with inflammatory bowel disease compared with uveitis associated with spondyloarthropathy. , 1997, A M A Archives of Ophthalmology.

[73]  A. Greenstein,et al.  Intra-abdominal abscess in regional enteritis. , 1991, Annals of surgery.

[74]  M. Grieco,et al.  Toxic megacolon complicating Crohn's colitis. , 1980, Annals of surgery.